Viewing Study NCT00950859

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2026-02-02 @ 12:56 AM
Study NCT ID: NCT00950859
Status: COMPLETED
Last Update Posted: 2015-12-04
First Post: 2009-07-23
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir
Sponsor: ViiV Healthcare
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Infection, Human Immunodeficiency Virus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None treatment experienced View
None HIV Infection View
None raltegravir resistance View
None GSK1349572 View
None optimized background regimen View
None integrase inhibitor View